PBLS · Parabilis Medicines, Inc. · Debt
$29.79
+0.54 (+1.85%)
At close · Nov 4
Return incl. dividend (before tax)
Market Cap
$3.70B
Shares
123.53M
Volume · Nov 4
501.62K
Avg daily vol (3M)
887.95K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current debt and lease obligations | 2026-06-30 | USD 5,710,000 | 10-Q filed 2026-08-13 |
| Current finance lease liabilities | 2026-06-30 | USD 669,000 | 10-Q filed 2026-08-13 |
| Current long-term debt and lease obligations | 2026-06-30 | USD 726,000 | 10-Q filed 2026-08-13 |
| Current operating lease liabilities | 2026-06-30 | USD 7,592,000 | 10-Q filed 2026-08-13 |
| Current portion of long-term debt | 2026-06-30 | USD 5,710,000 | 10-Q filed 2026-08-13 |
| Noncurrent finance lease liabilities | 2026-06-30 | USD 1,128,000 | 10-Q filed 2026-08-13 |
| Noncurrent debt carrying amount | 2026-06-30 | USD 700,000 | 10-Q filed 2026-08-13 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 32,413,000 | 10-Q filed 2026-08-13 |
| Short-term borrowings | 2026-06-30 | USD 5,000,000 | 10-Q filed 2026-08-13 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1657677
CUSIP
698955101
13F (30d)
17 filings
17 filers
Visit website
Investor relations